Production has ceased and an urgent investigation has been launched after two employees at a newly opened Australian nuclear medicine facility at Lucas Heights were exposed to an unsafe dose of radiation late last week. Just two weeks after it was granted a licence to enter into full domestic production , the Australian Nuclear Science and Technology Organisation (Ansto) has confirmed production at its new $168m nuclear medicine facility has been halted after “a safety incident” on Friday morning. Ansto said three of its workers were “attended to by radiation protection personnel” after the incident, in which contamination was detected on the outside of a container holding 42 millilitres of the radioisotope molybdenum-99 (Mo-99). Two of those workers received a radiation dose above the legal limit roughly equivalent to a conventional cancer radiation therapy treatment, an Ansto spokesman said. Fault at Lucas Heights nuclear reactor halts production of medical […]